← Back

Wire · opportunities

Abbott initiates VOYAGER clinical trial for investigational Encantor™ software-guided ...

Published

20 November 2026

Topic

opportunities

◆ Sectors

Medtech

◆ Geography

Europe

◆ Source

Read at abbott.mediaroom.com →

◆ Verified

Fusion42 · 20 November 2026 · Fusion42 review

Abbott has launched the VOYAGER CE clinical trial in Europe and Australia to evaluate the safety and efficacy of its investigational Encantor software-guided balloon-expandable TAVI system for treating severe aortic stenosis. The trial aims to support regulatory approval and provides a new tool for precise valve implantation tailored to patient anatomy.

This Wire brief sits within Fusion42's coverage of Medtech, and 3 sources have reported it between 19 Nov 2026 and 20 Nov 2026.

◆ ◆ The Wire takeaway

You now have a new software-driven TAVI system trialled in Europe and Australia that aims to improve procedural precision and patient outcomes. Prepare to engage with teams looking for software-enhanced valve implantation options as approvals progress.

◆ Coverage

3 sources · first reported 19 Nov 2026 · latest 20 Nov 2026

◆ Related on Wire

◆ Topics

Medtechaortic-stenosistaviclinical-trialmedtechsoftware-guided